• U.S. Energy Information Administration estimates that about 50 percent of total U.S. crude oil production in 2017 was produced directly from tight oil or oil embedded in low-permeable shale, sandstone and carbonate rock formations
• Petroteq’s patented clean technology extracts heavy oil from oil sands, oil shale deposits and shallow oil deposits in environmentally safe and sustainable method
• Advanced technologies and efficiencies for extraction of oil and gas from liquid-rich shale credited with moving U.S. back to top of global energy sector
• Petroteq preparing to produce 1,000 barrels of oil per day, with 8,000 bpd target
• Continuity testing complete as Petroteq plans to begin extraction during Q3 2018

A shale boom has helped send U.S. crude oil production surging above 10 million barrels per day (bpd) for the first time since the 1970s, according to a monthly report from the U.S. Energy Information Administration (EIA), a Reuters article states (http://ibn.fm/6JU36). The EIA estimates that, in 2017, about 4.67 million barrels per day of crude oil – or 50 percent of total U.S. crude oil production – were produced directly from tight oil resources in the United States. Tight oil is oil embedded in low-permeable shale, sandstone and carbonate rock formations

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), a fully integrated oil and gas company focused on the development and implementation of a new, proprietary technology for oil extraction, is in a prime location for contributing to the booming U.S. shale oil market as it makes final arrangements for continuous operations at its Asphalt Ridge facility in northeastern Utah. Petroteq’s closed-loop extraction process uses no water, produces zero greenhouse gas, zero waste and requires no high temperatures. Its aim is to extract commercial amounts of crude oil from Utah’s desert tar sand rock through a crushing and recyclable solvent distilling operation.

Petroteq recently completed continuity testing at Asphalt Ridge as it builds up to full capacity extraction of 1,000 barrels of oil per day utilizing its disruptive, environmentally friendly technology, a company news release states (http://ibn.fm/7OKRI). The Utah site is a 2,541-acre mineral lease with an expected yield of about 87.5 million barrels over the project’s lifespan. As operations get up to full speed, the company is optimistic that it can increase its output to 8,000 barrels per day by late 2020 or early 2021 (http://ibn.fm/O9UFd).

“We continue to focus on becoming the first environmentally friendly oil sands mining facility,” company President Jerry Bailey stated in a news release. “I am extremely impressed with the work completed by our site operations team. As I review all 14 operating processes that comprise the ten stages of our facility, I have to mention the dedication and experience of our field team.”

Petroteq also recently announced that it has engaged MetzOhanian, a software engineering firm in Austin, Texas, that will help develop applications for the company’s PetroBLOQ platform. MetzOhanian specializes in blockchain engineering, supply chain management software development and digital security consulting. MetzOhanian will be working with PetroBLOQ to develop blockchain applications aimed at increasing supply chain transparency and efficiency in the oil and gas sector, according to a company news release (http://ibn.fm/Xz04o).

“While we believe we are in the early days of blockchain application in the energy industry, the potential for PetroBLOQ’s blockchain principles to create a technology consortia’s for remediation, and reclamation projects is equally as compelling,” David Sealock, CEO of Petroteq, stated in the release. “We anticipate that as interest grows in leveraging Petroteq’s proprietary technology for surface oil sands mining, the remediation and cleaning of contaminated sites and oil waste reclamation will come to the forefront. We expect that the integration of technologies provides the possibility of creating long term investments in the profit potential of something as game changing as blockchain.”

For more information, visit the company’s website at www.Petroteq.energy

• SinglePoint’s investment allows social betting platform StakeHaul to develop payment solution
• Payment option and marketing strategy put in place to catch start of fall sports season
• StakeHaul’s membership and betting volume experiencing strong growth

Technology investment company SinglePoint, Inc. (OTCQB: SING) has injected more funds into an innovative peer to peer betting app, in time for the start of the fall sports season, according to a company press release (http://ibn.fm/wsKc8).

StakeHaul is a mobile platform that allows users to carry out social betting. SinglePoint president Wil Ralston said that the investment has allowed StakeHaul to develop a payment solution and fund a marketing strategy in time to capture traffic from sports fans who wish to make wagers with their friends and family. Speaking to MoneyTV (http://ibn.fm/nBHtz), Ralston said, “You could bet on anything you want to between you and your peers.”

“We’re really excited, especially because we’ve been able to implement a payments option, which really gives StakeHaul a path towards monetization: being able to take a percentage of every transaction, which we here at SinglePoint have deep experience in because of all the credit card experience and processing knowledge we have in that arena,” Ralston added.

The SinglePoint president explained that his company invested additional funding into StakeHaul to help it get to a level where it is “actually able to take credit card processing, be able to dabble in a little bit of cryptocurrency so that users can actually bet between themselves and then pay up on those bets.”

StakeHaul, available for both Android and Apple devices, has been downloaded over 70,000 times since its launch and has experienced strong, double-digit growth in user numbers and betting volumes. The app is developing the capacity to allow betting transactions using cryptocurrency, which would make it the first platform of its kind with such functionality.

With the sports betting industry worth an estimated $150 billion and a Supreme Court ruling earlier this year paving the way for legalized betting (http://ibn.fm/jQ0Cb), StakeHaul is in a position to capitalize significantly on the industry. It’s estimated that at least one third of Americans place a bet on at least one sports event per year, and 97 percent of these people place their bets outside of casinos, according to the American Gaming Association (http://ibn.fm/erzTJ).

In a news release, StakeHaul founder Jeffrey Lippert said, “All in all, our unique features, our ease of use, and the legal momentum behind betting in the U.S. makes our opportunity not just a home run, but a grand slam.”

Investing in StakeHaul is part of SinglePoint’s strategy of acquiring companies that need capital investment and technology integration to boost its own growth. The company’s portfolio currently includes mobile payments, ancillary cannabis services and blockchain solutions.

“Everything that we do, we try to wrap in ‘how can this fit into SinglePoint’s model?’ Whether it’s an acquisition, what kind of technology can we supply to make it more efficient? Can we bring in more payment systems to make it more efficient? So, really, everything SinglePoint does, it comes back to our backbone of payments and technology development,” Ralston said.

For more information, visit the company’s website at www.SinglePoint.com

• Revenue up by C$1.2 million in Q2 and by overall C$4 million in the first six months of the year
• Company secures 12-month extraction deals with two leading brands
• Sunniva takes strides toward increasing vertical integration

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a company that cultivates, processes and distributes cannabis, has announced its second quarter financial results, detailing milestones and achievements both for the second quarter and the first half of 2018 (http://ibn.fm/fYMqF). Recapping the company’s developments over the past six months, CEO Dr. Anthony Holler said that Sunniva has moved closer toward its goal of full vertical integration, which is a key company strategy.

“We made great progress in Q2 2018 towards our goal of becoming a vertically integrated cannabis company in the U.S. In California, construction progressed at our phase one 325,000 square foot state-of-the-art Sunniva California Campus with completion targeted by the end of this year and first harvest expected in Q1 2019,” Holler stated in a news release. “Our extraction facility began generating revenue this quarter. We continue to secure new contracts and are excited about the future revenue opportunities in this and other vertical channels that maximize the synergies with our Full-Scale Distributors device business.”

In June of this year, Sunniva entered 12-month extraction services agreements with two leading California brands for its Sun-Oil Facility. Under the agreements, wholly owned subsidiary CP Logistics LLC will provide distilled oil products for Farmacy Phactory, a producer of high-terpene strains of cannabis. CP Logistics will also produce high quality distilled oil products for Cali Gold, a legacy California cannabis brand specializing in high-end chocolates. The distilled products are to be used in vaporization cartridges.

Holler explained that the company’s main focus in California and the U.S. is to leverage its cultivation and extraction facilities to aggressively pursue upstream distribution and retail opportunities with the purpose of achieving full vertical integration from seed to sale. This will include the launch of Sunniva-branded product lines in various categories, such as flower, extracted products, vaporizers and beverages.

Speaking of the company’s operations north of the border, Holler added, “In Canada, we received our Confirmation of Readiness letter for a license from Health Canada and broke ground and commenced construction on the 759,000 square foot Sunniva Canada Campus in Okanagan Falls, British Columbia. Our Natural Health Services’ clinics reported another strong quarter of revenue generation and together with the future production from the Sunniva Canada Campus, provide a solid foundation for future Canadian growth opportunities.”

In addition, Natural Health Services (NHS), another wholly owned Sunniva subsidiary, opened its seventh clinic in Windsor, Ontario. NHS is Canada’s largest referral network of cannabis-related clinics and trained health professionals. NHS revenues contributed C$5.8 million to the company’s revenue in the six months ended June 30, 2018.

During this period, the company’s total revenue amounted to C$9.6 million, against a net loss of C$11.2 million, compared to a C$11.7 million loss in the same period last year.

The company’s expansion over the past months contributed to increased administration and general expenses, which went up by C$5.9 million in the six months ended June 30. Advisory expenses and costs related to the company’s publicly-listed status also added to the raised administration costs.

Other highlights mentioned in the company’s Q2 2018 press release include an additional 12-month extraction services agreement CP Logistics sealed with Pure Applied Sciences, Inc., a wholly-owned subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), for the extraction facility in California, and construction progress at the Sunniva California Campus. The cGMP-compliant greenhouse facility in Cathedral City is set to commence phase one operations – extraction of 50,000 kg per year – in Q4 2018, with the first harvest expected in Q1 2019. The facility is designed to eventually reach an estimated annual output of 60,000 kg of dry cannabis at capacity.

For more information, visit the company’s website at www.sunniva.com

• Demand for cobalt in vehicle battery materials expected to grow more than 40 percent in 2018
• Prices for cobalt metal hit their highest levels in 10 years in the first half of 2018, reaching over $90,000 per ton on the London Metal Exchange
• First Cobalt acquired 100 percent ownership of promising Idaho Iron Creek property, brought in additional drilling rigs
• Results expected soon from preliminary metallurgical work and maiden resource estimate from broad zones of cobalt-copper mineralization at Iron Creek Project

A tightening market and projected shortages of cobalt – a key battery metal used in everything from smartphones to electric vehicles, electronics and defense systems – is generating concern around the world, industry analysts report. Cobalt prices have tripled over the past two years, posing a threat to how quickly the electric vehicle market can grow in the near future, as noted in an article published by Bloomberg (http://ibn.fm/X90oc). Additionally, concerns over the methods being used by the politically unstable Democratic Republic of the Congo, where 60 percent of the world’s cobalt is produced, remain a factor for many of the world’s largest consumers of cobalt.

Vertically integrated pure-play cobalt company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) has consciously and strategically placed its efforts into its North American assets such as the Iron Creek Project in Idaho and the Greater Cobalt Project in the Canadian Cobalt Camp, which holds more than 50 past producing mines. The company also owns the only permitted cobalt refinery in North America capable of producing battery materials. First Cobalt recently announced that it has acquired 100 percent ownership of the Iron Creek property, where a maiden mineral resource estimate is anticipated any day.

First Cobalt president and CEO Trent Mell notes that a $9 million investment into Iron Creek has allowed the company to accelerate its drilling program there. In fact, First Cobalt is fully funded to complete its work programs in the U.S. and in Canada beyond the end of this year and into 2019, a company news release states (http://ibn.fm/tSPfb). Iron Creek’s promising potential includes results from recent drilling that indicate two broad zones of cobalt-copper mineralization that extend well beyond the limits of the historic resource.

With demand across most major end-use applications set to increase and the battery sector alone expected to enjoy double-digit growth over the coming decade, the market is gearing itself up for a sustained period of unprecedented consumption growth, according to metals and minerals research firm Roskill (http://ibn.fm/fJJwN). Some companies, such as Apple, BMW and Volkswagen, are reportedly negotiating to secure cobalt supplies directly from producers in an effort to safeguard their own supplies for future use, as detailed by CNBC (http://ibn.fm/mixih).

First Cobalt is actively working to create a North American solution to many of the problems facing cobalt consumers now and in the future. The company’s strategy of exploring, developing and refining material in North America for sale back into the American battery market is well underway. As such, First Cobalt is strategically positioned to be at the forefront of the cobalt-driven battery movement in the coming years.

For more information, visit the company’s website at http://ibn.fm/FTSSF

• Initial core-sampling assays at Marifil’s San Roque property show gold and silver among four drill holes, with lead and zinc assays pending
• The company believes that the site has more than 100 million metric tons of mineralized earth with significant levels of gold, silver, indium, lead and zinc
• Company is continuing to build assets in world-famous ‘Lithium Triangle’ in hopes of supplying key strategic metal

Canada-based Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) has released the initial results of its latest core-sampling campaign at an Argentine exploration site believed to contain significant quantities of gold and silver.

“The drilling at our flagship asset at San Roque has been highly anticipated by the Company and its stakeholders for many years. Positive results at San Roque have the ability to significantly increase the fundamental value of the Company and bring the Property one step closer to being considered an economic minerals deposit,” Marifil President and CEO Robert Abenante stated in a June news release (http://ibn.fm/Meln9).

The preliminary assay results for its diamond core drilling program used four HQ-size core holes totaling 846 meters (2,776 feet) to explore the company’s project area in the Province of Rio Negro, near the Atlantic coast. They bring the company’s exploration total to 112 holes through 16,683 meters (54,734 feet) at the San Roque site, and every one of the drill holes has intercepted some degree of mineralization, indicating an extensive system of mineralization over several square kilometers. Mineralization is open in all directions and at depth, or, in other words, its endpoint hasn’t yet been found, although some of the drill holes have been well below the company’s established cut-off grade.

According to Marifil’s September 11 report on the four latest drill holes numbered MF-DDH 56 through MF-DDH 59, holes 56, 58 and 59 were drilled as step-outs from previous holes drilled in 2011, and returned results that add significantly to the prospectiveness of the two zones in play. Hole MF-DDH 57 was an exploratory step-out along a linear geophysical anomaly that the drilling found to be caused by pyrite-rich rock of no economic value, however the first 50 meters (164 feet) intersected “noteworthy zinc mineralization” that justifies a follow-up exploratory drill hole, according to the company (http://ibn.fm/34Xtr).

The report describes MF-DDH 58 as showing lead and zinc mineralization in all 148 meters (486 feet) of the drill cores but notes that complete lead and zinc assays are still pending. Its assays for gold show an average of half gram per metric ton throughout two intercepts which total 83 meters (272 feet). The report says this mineralization is still open in several directions.

Holes MF-DDH 56 and MF-DDH 59 are in a separate area about 1.5 km south of MF-DDH 58, where drilling intercepted 35 meters of 2.27 grams per metric ton of gold and 42.6 grams per metric ton of silver in 2011, and the new assay runs show correlative gold mineralization, according to the company.

Alex Stewart Argentina S.A. in Mendoza, Argentina, is providing the certified assay results for the 582 drill core samples.

Marifil has arranged a new round of non-brokered private placement funding of up to 10 million units for gross proceeds of up to $1 million, subject to government approval. Each unit will consist of one common share and one warrant for a future share purchase.

The San Roque property does not yet have a reportable Canadian NI 43-101-compliant resource. However, based on findings of the extensive drilling cited above, the company believes that more than 100 million metric tons of mineralized earth underlies the property. This mineralized material contains a low level percentage of zinc and lead sulfides carrying potentially economic values in gold, silver and indium.

The company is focused on exploring for gold, lithium and cobalt — metals with significant commercial potential. Earlier this year, Marifil inked a definitive agreement with Argentine company Minera Esperanza S.A. to advance a five-year exploration plan at two lithium-bearing properties in the country’s Catamarca province, far to the north of San Roque, which would allow Marifil to purchase the properties if it finds them viable and thus expand its portfolio within the prolific “Lithium Triangle” centered in the border region between Argentina, Chile and Bolivia (http://ibn.fm/L2cGZ).

Lithium has obtained a status as a key strategic metal because of its role in the lithium-ion batteries that power electric vehicles and other in-demand computerized technology.

For more information, visit the company’s website at www.MarifilMines.com

• Hybrid-aeroponic agriculture approach pioneered by NASA ensures quality with controlled environment
• Cultivation IP that delivers higher yields, reduced costs and superior product
• In fast-developing cannabis market, effective branding is the key to success and profits

“A farmer has to be an optimist, or he wouldn’t be a farmer,” Will Rogers once quipped – a wry comment that might have been a reference to the vagaries of the weather. Erratic meteorological conditions are the farmer’s bane, unless, like Green Hygienics Holdings Inc. (OTC: GRYN), he’s employing space technology. Green Hygienics is a company that is targeting the high-end medical and adult-use recreational market with cannabis grown by an enhanced hybrid aeroponic method. It plans to generate revenues from the sales of the premium grade cannabis thus produced, as well as from the development and licensing of valuable IP from acquisitions and the creation of trusted global consumer brands.

Aeroponics is space-age agriculture. It’s a way to grow plants, without using soil, by suspending their root structures in air and regularly spraying them with a nutrient and water solution. The plants are hung in a manner that allows them to grow freely. The roots are enclosed and regularly sprayed with a mix of nutrients. Because the roots are in a closed loop system, the nutrient-water mix is used more efficiently by the plants, and less water is needed for them to grow and thrive.

The system has proven its effectiveness. NASA was able to grow Asian bean seedlings using an aeroponic system in the zero gravity environment of the Mir space station (http://ibn.fm/PVROb). The agency has been sponsoring such technologies since at least the 1990s, a major benefit of which is the capability to control the environment and exclude pathogens and other harmful agents.

Using its hybrid-aeroponic system, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The state-of-the-art, quality-controlled commercial cultivation methodology assures production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs. The technology produces quality cannabis faster than traditional methods since it requires no natural sunlight, eliminating the limitations imposed by day/night cycles. In addition, since the plants receive water and nutrients directly to their roots through a fine mist in a controlled environment, spoilage is reduced, and no unhealthy pesticides need be used because the environment is pest-free, keeping the product organic.

Precise control is maintained over every aspect of the cultivation process, which allows Green Hygienics to conserve natural resources. The plants are given the exact amount of nutrients and moisture required, as scientifically determined. As a result, the technology not only requires no pesticides or fungicides but also uses 90-95 percent less water. Moreover, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while significantly improving energy efficiency. Development of the technology has resulted in IP assets that include proprietary systems and apparatus, software, algorithms, custom-engineered hardware and a variety of premium brands.

In a cannabis market that’s likely to be flooded with a plethora of products, branding is going to play an important role in separating the sheep from the goats. Presently, Green Hygienics is launching several leading brands. Among them are ‘The Bridge Coffee House’ and ‘The Bridge Lounge’; ‘Vital’, a line of health and wellness products; and, of course, its ‘Green Hygienics Urban Agriculture’. With a mission of developing and establishing winning brands that promote healthy living at a time when pharmaceuticals and the food supply adversely affect our collective health, Green Hygienics aims to establish itself as a leader in the advancement of science-driven cannabis cultivation systems while providing its medical and recreational consumers with the best possible product and experience.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

• Developing the first off-the-shelf personalized immunotherapy for advanced breast cancer, Bria-OTS. Bria-OTS is designed to provide personalized treatment for ~90% of the advanced breast cancer patients without the high costs and difficult manufacturing associated with personalized treatments. The technology may be applicable to other cancers.
• Addressing an unmet need by targeting advanced breast cancer, from which an estimated 40,000 women have died in U.S. in 2017
• $1 billion-$5 billion market opportunity depending on patient treatment stage
• Results of two completed proof-of-concept human clinical trials showed rapid tumor shrinkage at multiple sites in advanced breast cancer patients without toxicity associated with other oncology treatments (e.g. chemotherapy).
• Bria-IMT has completed enrollment of a Phase I/IIa clinical trial with outstanding safety data and early signs of potent efficacy. Preliminary data from the Phase I/IIa trial is expected in 3Q2018.
• BriaDX, a companion diagnostic test, is currently in development along with Bria-IMT and Bria-OTS.
• Experienced management has been involved in over 10 drug approvals
• Significant near-term news-flow

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT with Keytruda (Keytruda is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy (Yervoy is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX. By using BriaDX to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

For more information, visit the company’s website at www.BriaCell.com

• Directors Yaqing Hu and Hui Zhu have stepped down for personal reasons
• Hongxiang Yu named chairman of the audit committee
• Yilei Shao appointed chair of the compensation committee

TMSR Holding Company Limited (NASDAQ: TMSR), a company that through its subsidiaries develops, produces and sells patented industrial and mining waste management solutions, has announced changes in the membership of its board of directors. Two directors, Yaqing Hu and Hui Zhu, have resigned from their roles on the board due to personal reasons. Their resignations took effect at the end of August, according to a company news release (http://ibn.fm/5Mr1U).

Stepping in to take their places will be Hongxiang Yu and Yilei Shao. The board appointed Yu as chairman of the audit committee, while Shao will serve as the chair of the compensation committee.

Yu has a strong track record of business leadership. He has served on the board of directors of American Lorain Corporation (NYSE: ALN), a food manufacturing company, and has held senior management positions with Hongrun Construction Group Co. Ltd., asset management and private equity investment firm Shanghai Highlights Asset Management Co. Ltd., and film investment company Tianjin Dragon Film Limited. Yu was educated at the University of Portsmouth in the United Kingdom, where he received a bachelor’s in international trade and a master’s in international human resources management.

Shao has been nominated to serve on the board of American Lorain Corporation. She is the founder and chief executive officer of Shanghai Jianshi Management Consulting Limited and worked for five years in New York as vice president of Goldman Sachs’ Credit Derivatives Department. Her educational background is in computer science, with a bachelor’s degree from Shanghai Jiao Tong University and a doctorate from Princeton University.

Paying tribute to the departing board members, TMSR Chairwoman Jiazhen Li said, “We’d like to thank Zhu and Hu for their leadership, guidance and dedication to TMSR while serving as members of the Board. We are also very delighted that Yu and Shao have agreed to join our Board and look forward to their expertise and insights in helping further strengthen our Board.”

TMSR, through its subsidiaries Shengrong Environmental and Wuhan HOST Coating Materials, is involved in the development, production and sale of industrial waste management systems and solutions. The company holds two international U.S. patents and six patents issued by the People’s Republic of China, including three invention patents and three utility model patents. Using these technologies, Shengrong Environmental recycles solid waste from a number of industries in the People’s Republic of China, extracting usable materials in processes that do not release dangerous chemical discharge.

TMSR’s technology allows the extraction and recycling of usable material from aluminum slag, red mud manganese tailings, copper mine tailings and iron mine tailings. In addition to its involvement in industrial and mining waste processing and recycling, TMSR also trades in iron ore and operates wine import and resale services.

For more information, visit the company’s website at www.TMSRHolding.com

• EMHTF named as a cannabis supplier for Newfoundland Labrador Liquor Corporation (NLC) to serve the adult use market of the entire province of Newfoundland and Labrador
• Pure Sunfarms, in which EMHTF is a 50-50 joint venture partner, has received from Health Canada an amendment permitting it to expand its cannabis production area to 550,000 sq. ft.
• EMHTF already has supply agreements with the Canadian provinces of British Columbia and Ontario; as a cannabis producer, it is ramping up operating facilities in British Columbia and Quebec

Emerald Health Therapeutics Inc. (TSX.V: EMH) (OTCQX: EMHTF) is well positioned in Canada in the adult use cannabis market, both as a supplier to several provinces and as a grower. Through its licensed subsidiary, Emerald Health Botanicals Inc. (“EHB”), it can sell in Canada both medical dried cannabis and cannabis oils (http://ibn.fm/knaK5).

EMHTF, based in Victoria, British Columbia, is focused on developing cannabis as a supplier and cultivator, developing value-added products for the pharmaceutical, nutraceutical and botanical markets with wellness and medical benefits.

Through its EHB subsidiary, it maintains a joint venture with Village Farms International Inc. Together, they operate Pure Sunfarms, which has an existing 1.1 million sq. ft. licensed greenhouse in Delta, British Columbia (Delta 3). An amendment to its cultivation license expands its cannabis production area to half of that facility. Full production is expected by mid-October (http://ibn.fm/KFdG4).

EMHTF also owns Agro-Biotech, a Quebec-based licensed cannabis grower operating a 75,000 sq. ft. licensed indoor facility. It is planning to add a 500,000 sq. ft. greenhouse in Metro Vancouver, Canada.

As a supplier, the company has expanded into a new market by being named by the Newfoundland Labrador Liquor Corporation as supplier to the province of Newfoundland Labrador in Canada for adult use cannabis starting in October. That is in addition to its prior agreements to supply both Ontario and British Columbia (http://ibn.fm/pG5tC).

“We’re proud to work with the NLC as a preferred Licensed Producer to serve Newfoundland and Labrador in the upcoming legal cannabis market,” Chris Wagner, CEO of Emerald, stated in a news release. “This represents the third provincial agreement for our team and we expect to share additional supply updates in the future.”

For more information, visit the company’s website at www.Emerald.care

• Cannabinoid molecule extraction, quantification mark early successes in PreveCeutical’s drug delivery development process
• PreveCeutical optimistic about prototypical spray applicators in development for cannabinoid therapies
• Clinical trials of cannabis-based therapeutics anticipated next year

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is celebrating the achievement of several key milestones in the development of the company’s proprietary Sol-gel program for the nasal delivery of select medications, where those medications can be expected to effectively reach the nervous system in order to accomplish their purposes in treating conditions ranging from anxiety to head concussion injuries, a company officer told market reporting outlet Proactive Investors Limited.

PreveCeutical Chief Research Officer Harry Parekh told Proactive Investors in a September 10 interview (http://ibn.fm/TphxA) that one significant advancement that the company has made is in the extraction of key cannabinoid molecules from one strain received from PreveCeutical’s licensed producer, Canadian cultivator and distributor Aurora Cannabis, Inc. (TSX: ACB) (OTCQX: ACBFF). PreveCeutical’s R&D department was able to validate the chemistry of the cannabinoids within a cannabinoid-rich mixture, measuring them against eight commercial cannabinoid standards over a broad concentration range.

The researchers were then able to quantify how many cannabinoids were present within the extract, ensuring that the amount fell well within the range of what Aurora had specified and clearing the way for the researchers to move forward in assaying four additional strains (http://ibn.fm/3p5NC).

“We’re very confident now moving forward, developing a standard operating procedure to extract it,” Parekh noted in the interview. “At PreveCeutical, we’re working with five different strains which have different concentrations of cannabinoids to THC, and the whole plan here is to develop a range of products which can then be personalized to the patient and also to the disease as the clinical trials data becomes available.”

Through the extraction work, PreveCeutical’s researchers will be able to create a library of chemically fingerprinted cannabinoid extracts that can then be optimized and incorporated into the company’s Sol-gel technology.

PreveCeutical’s ultimate aim is to use its Sol-gel formulations to deliver the cannabis-based therapeutics in a healthful, rapidly catalyzing non-smoked method to assist patients dealing with pain, inflammation, anxiety, seizures and other neurological disorders. The nasal application of the Sol-gels provides the means for the medication to cross the blood-brain barrier without having to run the gauntlet in the gut first, delivering medications with the fewest side effects possible.

Parekh said that the company expects to begin clinical trials by late next year. The research work is being conducted through PreveCeutical’s partner, the University of Queensland’s Pharmacy Australia Centre of Excellence. The university has received several prototypes from its contracted drug delivery device manufacturer for the in-development spray applicator that will ultimately be used to administer the Sol-gels, and it has been assessing their performance.

“We’ve now honed in on a couple of devices which are very promising with our Sol-gel platform,” Parekh said. “It’s interesting because I’ve attended a number of different seminars over the last six to 12 months, looking at other companies that are working in the spray area, and inadvertently when you listen to these seminars you understand some of the complexities that can arise because of the number of sprays that those patients will need to administer. You’re talking upwards of one or two dozen sprays every 24 hours, which is effectively the patient drinking it post-nasally. And so we believe at PreveCeutical we’re going to have the edge on this because our spray will gel as soon as it hits the nasal mucosa, avoiding any post-nasal swallowing, and therefore applications from maybe once or thrice a week will be what we’ll be targeting.”

PreveCeutical is expecting to take advantage of the heightened public interest in cannabis-related medications worldwide. Parekh said that the company has also ensured that the anticipated formulation will be safe for use by all ages from neonate to elderly, with no age-based detrimental effects, and the researchers are looking at multiple ways of channeling the dosage, such as wafers and tablets, in addition to the sprays.

At the same time, the drive to legalize cannabis may create challenges for the company, as much of the available supply is channeled toward recreational use instead of medicinal use, he said. However, PreveCeutical still anticipates a bright future of using its positioning to tailor its products’ well-defined chemistries and delivery methods to patients’ needs.

For more information, visit the company’s website at www.PreveCeutical.com